Holen Sie sich die Stockscreener-App
2.03
6.45%
-0.14
Qualigen Therapeutics Inc Aktie (QLGN) Neueste Nachrichten
Does Qualigen Therapeutics Inc. fit your quant trading modelWeekly Portfolio Update with ROI Focus - Newser
Is Qualigen Therapeutics Inc. forming a bottoming baseTechnical Setup Guide for Daily Watchlist - Newser
Statistical indicators supporting Qualigen Therapeutics Inc.’s strengthWatchlist Generator With Real-Time Entry - Newser
What MACD and RSI say about Qualigen Therapeutics Inc.Trade Alert System with Volume Analysis - Newser
Is Qualigen Therapeutics Inc. showing signs of accumulationFree Fundamental Growth Stock Analysis - Newser
Technical signs of recovery in Qualigen Therapeutics Inc.Daily Pattern Analysis with Return Forecast - Newser
What catalysts could drive Qualigen Therapeutics Inc. stock higher in 2025Discover hidden gems in the stock market - jammulinksnews.com
How Qualigen Therapeutics Inc. stock performs during market volatilityMonthly Trade Result and Signal Summary - Newser
What institutional investors are buying Qualigen Therapeutics Inc. stockCapitalize on market trends with confidence - jammulinksnews.com
How many analysts rate Qualigen Therapeutics Inc. as a “Buy”Capitalize on market trends with confidence - jammulinksnews.com
How does Qualigen Therapeutics Inc. generate profit in a changing economyPowerful growth strategies - jammulinksnews.com
How volatile is Qualigen Therapeutics Inc. stock compared to the marketAchieve breakthrough performance in the market - jammulinksnews.com
News impact scoring models applied to Qualigen Therapeutics Inc.Weekly Entry Signal Based Forecast Tool - newser.com
Evaluating Qualigen Therapeutics Inc. with trendline analysisLow Risk Strategy with Smart Entry Zones - newser.com
What analysts say about Qualigen Therapeutics Inc. stockFree Investment Portfolio Suggestions - jammulinksnews.com
Why is Qualigen Therapeutics Inc. stock attracting strong analyst attentionHigh-yield investments - jammulinksnews.com
When is Qualigen Therapeutics Inc. stock expected to show significant growthBuild wealth steadily with expert advice - jammulinksnews.com
What makes Qualigen Therapeutics Inc. stock price move sharplySuperior return velocity - jammulinksnews.com
What are the latest earnings results for Qualigen Therapeutics Inc.Extraordinary performance - jammulinksnews.com
What is Qualigen Therapeutics Inc. company’s growth strategyUncover the best stocks for explosive growth - jammulinksnews.com
Combining machine learning predictions for Qualigen Therapeutics Inc.Free Optimized Watchlist With Daily Adjustments - Newser
Full technical analysis of Qualigen Therapeutics Inc. stockSector-Wise Stock Strength Trend Analysis - Newser
Can Qualigen Therapeutics Inc. Overcome Bearish SentimentShort Term High Yield Stock Tips for Active Traders - metal.it
Has Qualigen Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewReal Trader Watchlist of Hot Stocks Released - metal.it
Will Breakout in Qualigen Therapeutics Inc. Sustain Through Next WeekCapital Preserving Trade Plan Templates Shared - beatles.ru
Published on: 2025-07-31 11:14:48 - metal.it
Qualigen Therapeutics Secures Nasdaq Compliance Extension - MSN
Bollinger Band Squeeze Points to Volatility in Qualigen Therapeutics Inc.Weekly Chart Analysis With Entry Advice Provided - metal.it
Qualigen Therapeutics Raises $4.5 Million Through Series A-3 Preferred Stock Placement - AInvest
Is This the Dip to Buy in Qualigen Therapeutics Inc.Accurate Technical Trend Reversal Picks Detected - metal.it
Sector Leaders Rotate Capital Into Qualigen Therapeutics Inc.Real-Time Trade Insights Spark Market Reactions - metal.it
Qualigen Therapeutics Inc. Crosses 200 Day MA — Signal or NoiseTriple Return Setup With Risk Control Explained - metal.it
Is it the right time to buy Qualigen Therapeutics Inc. stockStock Market Entry Points To Watch Now - jammulinksnews.com
Qualigen Therapeutics Announces $4.5M Private Placement - MSN
Qualigen Therapeutics Granted Patents for Cancer Drug in More Than 20 European Countries - 富途牛牛
Qualigen Therapeutics raises $4.5 million through private placement of Series A-3 Preferred Stock. - AInvest
Qualigen's Strategic Turnaround and Nasdaq Compliance: A Credible Path to Long-Term Value - AInvest
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status - The Manila Times
Qualigen Therapeutics' Nasdaq Compliance and Strategic Capital Raise: Assessing the Long-Term Viability of a Biotech in Crisis and Recovery - AInvest
Qualigen regains Nasdaq compliance with $4.5 million private placement By Investing.com - Investing.com Nigeria
Qualigen regains Nasdaq compliance with $4.5 million private placement - Investing.com Australia
Qualigen Therapeutics Updates on Nasdaq Communications and Listing Status - AInvest
Qualigen Secures Nasdaq Listing Status with $4.5M Strategic Funding, Addresses All Compliance Issues - Stock Titan
Published on: 2025-07-28 19:32:51 - metal.it
Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock - The Manila Times
Qualigen Therapeutics Secures $4.5 Million Private Placement for Cancer Treatment Research - AInvest
Cancer Drug Developer Qualigen Secures $4.5M From Institutional Investors for Treatment Pipeline - Stock Titan
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):